Neutrolis Inc
PrivateLast Round
Series B
Oct 29, 2025
Total Funding Raised
$33.56M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neutrolis Inc is a biotechnology company that develops precision therapies for autoimmune and inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neutrolis Inc Comparables
Compare Neutrolis Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ardiyon Bio | 85% | |
| Citryll | 81% | |
| Sonoma Biotherapeutics | 64% | |
Neutrolis Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 29, 2025 | ||||
| VC Round | Jul 8, 2025 | ||||
| VC Round | Feb 28, 2025 | ||||
| Series A | Dec 3, 2021 | ||||
| Grant | Aug 3, 2020 | ||||
Accelerator | Nov 28, 2017 |
Key People
Founding team and executive leadership
Neutrolis Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Prefix Capital | VC Round, Series A, Seed |
| PBJ Capital | VC Round, Series A |
| Pfizer | Accelerator |
| Morningside Group | Series A |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 46% MoM.
- Apr 15, 2026
Caren Deardorf appointed as Chief Business & Strategy Officer.
Neutrolis Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neutrolis Inc's valuation, stock price, and market status.